Fund Holdings — Euclidean Capital LLC

Total Portfolio Value
$238.00M
Total Bought
$39.97M
Total Sold
$115.79M
Net Transaction
-$75.82M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q2 2025
▲▼
Q3 2025
▲▼
Change
▲▼
Q2 2025
▲▼
Q3 2025
▲▼
Weight (%)
▲▼
Change
▲▼
VANGUARD INTL EQUITY INDEX F2,142,6842,578,184+435,500144,031184,00577.31%+39,974
ALECTOR INC1,307,8581,307,85801,8313,8711.63%+2,040
ORIC PHARMACEUTICALS INC(ORIC)989,410989,410010,04311,8734.99%+1,830
RAPT THERAPEUTICS INC82,23482,23406582,1210.89%+1,463
TENAYA THERAPEUTICS INC(TNYA)1,015,7051,015,70506211,6450.69%+1,025
PMV PHARMACEUTICALS INC(PMVP)2,627,6432,627,64302,7853,6791.55%+893
SURROZEN INC(SRZN)87,69687,69607841,1300.47%+346
FOGHORN THERAPEUTICS INC(FHTX)1,573,7611,573,76107,3977,6963.23%+299
SPDR S&P 500 ETF TR(SPY)4,1044,10402,5362,7341.15%+198
SURROZEN INC(SRZN)170,833170,8330330.00%0
ISHARES TR
MSCI INDIA ETF
2,425,144369,600-2,055,544135,03219,2418.08%-115,791
Page 1 of 1
Euclidean Capital LLC — 13F Holdings — Q3 2025 | TickerTrail